1. Home
  2. TRUG vs EVOK Comparison

TRUG vs EVOK Comparison

Compare TRUG & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRUG
  • EVOK
  • Stock Information
  • Founded
  • TRUG 1983
  • EVOK 2007
  • Country
  • TRUG United States
  • EVOK United States
  • Employees
  • TRUG N/A
  • EVOK N/A
  • Industry
  • TRUG
  • EVOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRUG
  • EVOK Health Care
  • Exchange
  • TRUG NYSE
  • EVOK Nasdaq
  • Market Cap
  • TRUG 7.0M
  • EVOK 7.7M
  • IPO Year
  • TRUG N/A
  • EVOK 2013
  • Fundamental
  • Price
  • TRUG $5.78
  • EVOK $4.43
  • Analyst Decision
  • TRUG Strong Buy
  • EVOK
  • Analyst Count
  • TRUG 1
  • EVOK 0
  • Target Price
  • TRUG $100.00
  • EVOK N/A
  • AVG Volume (30 Days)
  • TRUG 84.7K
  • EVOK 7.2M
  • Earning Date
  • TRUG 08-13-2025
  • EVOK 08-12-2025
  • Dividend Yield
  • TRUG N/A
  • EVOK N/A
  • EPS Growth
  • TRUG N/A
  • EVOK N/A
  • EPS
  • TRUG N/A
  • EVOK N/A
  • Revenue
  • TRUG $22,236,072.00
  • EVOK $11,594,083.00
  • Revenue This Year
  • TRUG $9.66
  • EVOK $57.82
  • Revenue Next Year
  • TRUG $48.94
  • EVOK $59.12
  • P/E Ratio
  • TRUG N/A
  • EVOK N/A
  • Revenue Growth
  • TRUG 8.40
  • EVOK 89.89
  • 52 Week Low
  • TRUG $5.00
  • EVOK $1.94
  • 52 Week High
  • TRUG $73.50
  • EVOK $12.32
  • Technical
  • Relative Strength Index (RSI)
  • TRUG 42.37
  • EVOK 53.72
  • Support Level
  • TRUG $5.00
  • EVOK $4.26
  • Resistance Level
  • TRUG $6.80
  • EVOK $4.73
  • Average True Range (ATR)
  • TRUG 0.72
  • EVOK 0.73
  • MACD
  • TRUG 0.27
  • EVOK -0.07
  • Stochastic Oscillator
  • TRUG 22.14
  • EVOK 25.95

About TRUG TRUGOLF HOLDINGS INC

TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games (including Links, a sports game for PC), hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

Share on Social Networks: